Exchange: CSE·Updated 04:00 PM EDT
About ABRT.CSE
Albert Labs International Corp. operates as a research and drug development company. It produces natural, pharmaceutical-quality psilocybin medicine to treat cancer-related distress. The firm focuses on improving patient access to psychedelic-assisted therapies through accelerated regulatory approval pathways. The company was founded on October 16, 2009 and is headquartered in Burnaby, Canada.